Snack Smarter: Diabetes-Friendly Treats for Busy Days
Have you ever wanted to pack snacks for a long day ahead but didn’t know what to bring? Check out these tips and recipes…
This study is for patients with Type 1 Diabetes, using an insulin pump, and currently have obesity. Participants will add either semgalutide (Ozempic) or a placebo to their current treatment. Ozempic is a once-weekly injection approved for Type 2 Diabetes and can help with weight loss.
The goal of the study is to see if adding Ozempic can help patients with Type 1 Diabetes lose body weight and improve blood sugar control.
All participants enrolled in this study will receive study meds at no charge and will be compensated for their time and travel.
To take part in the study, participants should be:
See if you qualify
CEO and Medical Director
Director of Clinical Services
Director of Clinical Research
Clinical Research Coordinator
Clinical Research Coordinator
Navigator/Study Start-up Manager
Clinical Research Coordinator
Clinical Research Coordinator